Physicochemical and Cytotoxicity Characterization of Injectable Bone Substitute Based on Hydroxyapatite - Chitosan Streptomycin for Spinal Tuberculosis Cases

• Main Authors: Systi Adi Rachmawati, .-, Dyah Hikmawati*, .-, Aniek Setiya Budiatin, .-, Alfian Pramudita Putra, .-
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: https://doi.org/10.4028/www.scientific.net/MSF.966.133 2019
• Subjects: Q Science; Q Science (General); QC Physics; QC1 Physics (General)
• Online Access: https://repository.unair.ac.id/127544/2/C02.%20Fulltext.pdf; https://repository.unair.ac.id/127544/3/C02.%20Penilaian%20dan%20Validasi.pdf; https://repository.unair.ac.id/127544/4/C02.%20Simillarity.pdf; https://repository.unair.ac.id/127544/1/C02.%20Bukti%20Korespondensi.pdf; https://repository.unair.ac.id/127544/; https://www.scientific.net/MSF.966.133

Injectable bone substitute (IBS) based on hydroxyapatite, chitosan and streptomycin has been developed succesfully. The IBS was made by mixturing 20% w/v hydroxyapatite and varying the chitosan ratio of 60:40, 65:35, 70:30, 75:25 and adding streptomycin as antibiotic substance. The mixture was added...